Effect of Targeted vs. Standard Fortification of Breast Milk on Growth and Development of Preterm Infants (≤32 Weeks): Results from an Interrupted Randomized Controlled Trial
Nutrients · 2023
DOI: 10.3390/nu15030619 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Joanna Seliga-Siwecka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology and Neonatal Intensive Care, Medical University of Warsaw, 02-091 Warszawa, Poland. Hauptthemen laut MEDLINE: Infant, Premature, Milk, Human. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundacja NUTRICIA, Nutricia Foundation Poland.
Themen: Neonatologie
Abstract (Originalsprache)
Human milk is recommended for very low birth weight infants. Their nutritional needs are high, and the fortification of human milk is a standard procedure to optimize growth. Targeted fortification accounts for the variability in human milk composition. It has been a promising alternative to standard fixed-dose fortification, potentially improving short-term growth. In this trial, preterm infants (≤32 weeks of gestation) were randomized to receive human milk after standard fortification (HMF, Nutricia) or tailored fortification with modular components of proteins (Bebilon Bialko, Nutricia), carbohydrates (Polycal, Nutricia), and lipids (Calogen, Nutricia). The intervention started when preterms reached 80 mL/kg/day enteral feeds. Of the target number of 220 newborns, 39 were randomized. The trial was interrupted due to serious intolerance in five cases. There was no significant difference in velocity of weight gain during the supplementation period (primary outcome) in the tailored vs. standard fortification group: 27.01 ± 10.19 g/d vs. 25.84 ± 13.45 g/d, p = 0.0776. Length and head circumference were not significantly different between the groups. We found the feasibility of targeted fortification to be limited in neonatal intensive care unit practice. The trial was registered at clinicaltrials.gov NCT:03775785.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neonatology and Neonatal Intensive Care, Medical University of Warsaw, 02-091 Warszawa, Poland.
- Department of Clinical Sciences, Pediatrics, Umeå University, 901 87 Umeå, Sweden.
ORCID-Profile: Joanna Seliga-Siwecka, Justyna Fiałkowska
Förderung
- Fundacja NUTRICIA
- Nutricia Foundation Poland
Zitieren
APA
Seliga-Siwecka, J., Fiałkowska, J., & Chmielewska, A. (2023). Effect of Targeted vs. Standard Fortification of Breast Milk on Growth and Development of Preterm Infants (≤32 Weeks): Results from an Interrupted Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu15030619
Vancouver
Seliga-Siwecka J, Fiałkowska J, Chmielewska A. Effect of Targeted vs. Standard Fortification of Breast Milk on Growth and Development of Preterm Infants (≤32 Weeks): Results from an Interrupted Randomized Controlled Trial. Nutrients. 2023. doi:10.3390/nu15030619
BibTeX
@article{SeligaSiwecka2023,
author = {Seliga-Siwecka, Joanna and Fiałkowska, Justyna and Chmielewska, Anna},
title = {Effect of Targeted vs. Standard Fortification of Breast Milk on Growth and Development of Preterm Infants (≤32 Weeks): Results from an Interrupted Randomized Controlled Trial},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15030619}
}
EUVIMED